European Archives - Page 1323 of 1449 - European Medical Journal

Introducing EMJ Hepatology 4.1

United Kingdom, May 31, 2016: Welcome to the latest edition of EMJ Hepatology, which provides a collection of articles on the latest hepatology research…

Review of the 51st International Liver Congress™ 2016

The historic architecture of Barcelona, Spain, was the backdrop to this year’s annual ILC congress, marking its 51st birthday. The city of Barcelona…

Welcome to the Real World: Hepatitis C Virus Clinical Trials to Patient Realities

The symposium addressed the efficacy and safety of compounds currently available for treatment of hepatitis C virus (HCV) and chronic kidney disease…

EMJ Hepatology 4.1 2016

Welcome to the latest edition of EMJ Hepatology, which provides a collection of articles on the latest hepatology research and news from…

Editor’s Pick: Clinical, Histological, and Molecular Classification of Hepatocellular Carcinoma: How Do They Get Along?

Hepatocellular carcinoma (HCC) will soon become a prominent part of the medical and economic burden on many Western countries’ healthcare systems.

The International Liver Congress (ILC) 2016: Rifaximin Use in Cirrhosis-Related Hepatological Disorders and New Perspectives

Rifaximin (RFX)-α is a broad-spectrum antibiotic that targets commensal gut bacteria and reduces the excess ammonia produced by the gut bacteria of…

Nonsurgical Treatment for Localised Hepatocellular Carcinoma

The majority of patients (worldwide) diagnosed with hepatocellular carcinoma (HCC) in 2016 will not be candidates for a potentially curative therapy…

Fatty Liver Disease: A Crosstalk Between Lipid Species

he role of different lipid species such as free fatty acids and sphingolipids in non-alcoholic fatty liver disease (NAFLD) has been extensively studied…

Immunopathogenesis of Hepatitis B Virus Infection and Related Complications

Chronic hepatitis B (CHB) is a serious consequence of hepatitis B virus (HBV), which infects and replicates in the liver.

Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usually associated with obesity and metabolic syndrome, are…